Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer.
Sharifi MN, Feng E, Rydzewski NR, Taylor AK, Sperger JM, Shi Y, Helzer KT, Bootsma ML, Carreno V, Chang AH, Nunamaker LA, Blitzer GC, Shang TA, Subramanian A, Bjartell A, Josefsson A, Wikström P, Feng E, Kohli M, Yang R, Dehm SM, Small EJ, Aggarwal R, Quigley DA, Lang JM, Zhao SG, Sjöström M.Mol Oncol. 2025 Aug;19(8):2348-2365. doi: 10.1002/1878-0261.70001. Epub 2025 Feb 22.PMID: 39985777
Lossless Altered Histone Modification Analysis System (LAHMAS).
Kauffman ZJ, Koesser K, Helzer KT, Sharifi MN, Heninger E, Li C, Juang DS, Jarrard DF, Zhao SG, Haffner MC, Beebe DJ, Lang JM, Sperger JM.Lab Chip. 2025 Aug 5;25(16):4059-4070. doi: 10.1039/d5lc00060b.PMID: 40620045
The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library.
Gunaratne GS, Gallant JP, Ott KL, Broome PL, Celada S, West JL, Mixdorf JC, Aluicio-Sarduy E, Engle JW, Boros E, Meimetis L, Lang JM, Zhao SG, Hernandez R, Kosoff D, LeBeau AM.Commun Biol. 2025 Aug 13;8(1):1210. doi: 10.1038/s42003-025-08610-x.PMID: 40804296
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
Cash T, Marachelian A, DuBois SG, Chi YY, Baregamyan A, Groshen SG, Jonus HC, Shamirian A, Crowley M, Goodarzian F, Acharya PT, Pawel B, Erbe AK, Shahi A, Zaborek J, Kennedy E, Asgharzadeh S, Villablanca JG, Pinto N, Weiss BD, Mosse YP, Desai AV, Macy ME, Granger M, Vo KT, Sondel PM, Matthay KK, Park JR, Goldsmith KC.J Clin Oncol. 2025 Aug;43(22):2490-2501. doi: 10.1200/JCO-24-02612. Epub 2025 Jun 23.PMID: 40549985 Clinical Trial.
Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1.
Lafargue A, Wang H, Chettiar ST, Gajula RP, Shetty AC, Song Y, Simons BW, Khan MA, Nguyen T, Tseng HW, Chang J, Waters DN, Chan A, Lam C, Carrieri FA, Smack C, Connis N, Chowdhury DD, Nugent K, Siddiqui I, Taparra K, Rezaee M, Zachara N, Morris ZS, McFarland C, Abdulkadir SA, Hann CL, Tran PT.Neoplasia. 2025 Aug;66:101179. doi: 10.1016/j.neo.2025.101179. Epub 2025 May 22.PMID: 40409044
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer.
Mout L, Moreno-Rodriguez T, Grillo G, Nand A, Keshavarzian T, Bahl S, Kang K, Bootsma M, Minnee E, Zhou S, Burns KH, Corey E, Nelson P, Dehm SM, Zhao SG, Zwart W, Feng F, Quigley D, Lupien M.bioRxiv [Preprint]. 2025 Aug 12:2025.08.08.668693. doi: 10.1101/2025.08.08.668693.PMID: 40832168
ACR-ACNM-ARS-SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride.
Akin EA, Wallner PE, Alexander S, Barry P, Colletti PM, Deville C Jr, Kuo PH, Kishan A, Morris Z, Mulugeta PG, Pandit-Tasker N, Rabatic BM, Saboury B, Sharma N, Ghesani MV, Subramaniam RM, Small W Jr, Schechter NR.Am J Clin Oncol. 2025 Aug 25. doi: 10.1097/COC.0000000000001245. Online ahead of print.PMID: 40851434
Dendrimer Conjugates with PD-L1-Binding Peptides Enhance In Vivo Antitumor Immune Response.
Kim D, Lee JW, Rawding PA, Iida M, Kim C, Kostecki KL, Poellmann MJ, Crossman B, Liu AS, Kim Y, Wheeler DL, Hong S.Adv Healthc Mater. 2025 Aug;14(20):e2500551. doi: 10.1002/adhm.202500551. Epub 2025 Apr 17.PMID: 40244214 Free PMC article.
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.
Kerr CP, Sheehan-Klenk J, Grudzinski JJ, Adam DP, Nguyen TPT, Ferreira CA, Bates AM, Jin WJ, Kwon O, Olson AP, Lin W, Hyun M, Jagodinsky JC, Powers M, Sriramaneni RN, Clark PA, Shea AG, Comas Rojas H, Choi C, Massey CF, Zangl LM, Pinchuk AN, Aluicio-Sarduy E, Kim K, Engle JW, Hernandez R, Bednarz BP, Weichert JP, Morris ZS.Cancer Immunol Res. 2025 Aug 1;13(8):1190-1206. doi: 10.1158/2326-6066.CIR-24-1191.PMID: 40439704
In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma.
Kosharek AT, Zuleger CL, Glass WS, Eickhoff J, Sondel PM, Vail DM, Albertini MR.PLoS One. 2025 Aug 19;20(8):e0330200. doi: 10.1371/journal.pone.0330200. eCollection 2025.PMID: 40828812
Outcomes of Patients With Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
Vuong SQ, Liu M, Tsarovsky NW, Wudtke JD, Wallat EM, Bayliss RA, Bassetti MF, Baschnagel AM.Clin Lung Cancer. 2025 Aug 5:S1525-7304(25)00161-5. doi: 10.1016/j.cllc.2025.07.017. Online ahead of print.PMID: 40883165
ImmunoPET Demonstrates that Co-Targeting GD2 and B7-H3 with Bispecific Antibodies Enhances Tumor Selectivity in Preclinical Melanoma Models.
Rosenkrans ZT, Erbe AK, Clemons NB, Feils AS, Medina-Guevara Y, Jeffery JJ, Barnhart TE, Engle JW, Sondel PM, Hernandez R.Bioconjug Chem. 2025 Aug 20;36(8):1595-1603. doi: 10.1021/acs.bioconjchem.5c00016. Epub 2025 Jul 31.PMID: 40741919
Functional Imaging of Changes in Lung Function Before and After Radiation Therapy of Lung Cancer.
Percy JL, McIntosh MJ, Wallat E, Staab KR, Hahn AD, Carey KJ, Barton GP, Baschnagel AM, Bayouth JE, Bello RM, Perlman SB, Fain SB.Adv Radiat Oncol. 2025 Jun 20;10(8):101810. doi: 10.1016/j.adro.2025.101810. eCollection 2025 Aug.PMID: 40611878
Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand Therapy and Assess Treatment Response.
Floberg JM, Kyriakopoulos CE, Cho SY.Adv Radiat Oncol. 2025 May 10;10(8):101805. doi: 10.1016/j.adro.2025.101805. eCollection 2025 Aug.PMID: 40697966